ClinicalTrials.Veeva

Menu

Utah Study Evaluating Apneic Oxygenation for Emergency Department Intubation (USE AP OX)

Intermountain Health Care, Inc. logo

Intermountain Health Care, Inc.

Status

Unknown

Conditions

Intubation

Treatments

Other: Apneic oxygenation
Other: Pre-oxgenation with NRB, NIPPV, BVM

Study type

Interventional

Funder types

Other

Identifiers

NCT02961933
1050200

Details and patient eligibility

About

This study will determine rates of first pass success without hypoxemia in emergency department intubations with and without the use of apneic oxygenation by nasal cannula.

Enrollment

500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients requiring emergent Rapid Sequence or Delayed Sequence endotracheal intubation with administration of a neuromuscular blocker (Succinylcholine, Rocuronium)

Exclusion criteria

  • Known prisoners
  • Patients in cardiac arrest
  • Patients who are intubated without the use of neuromuscular blockade (i.e., cardiac arrest, awake intubation).

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

500 participants in 2 patient groups

Apneic oxygenation
Experimental group
Treatment:
Other: Apneic oxygenation
non-apneic oxygenation
Active Comparator group
Treatment:
Other: Pre-oxgenation with NRB, NIPPV, BVM

Trial contacts and locations

1

Loading...

Central trial contact

Valerie Aston, MBA, RT

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems